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a b s t r a c t
During HIV-1 morphogenesis, the precursor Gag protein is processed to release capsid (CA) proteins that
form the mature virus core. In this process, the CA proteins assemble a lattice in which N-terminal
domain (NTD) helices 1–3 are critical for multimer formation. Mature core assembly requires refolding of
the N-terminus of CA into a β-hairpin, but the precise contribution of the hairpin core morphogenesis is
unclear. We found that mutations at isoleucine 15 (I15), between the β-hairpin and NTD helix 1 are
incompatible with proper mature core assembly. However, a compensatory mutation of histidine 12 in
the β-hairpin to a tyrosine was selected by long term passage of an I15 mutant virus in T cells. The
tyrosine does not interact directly with residue 15, but with NTD helix 3, supporting a model in which
β-hairpin folding serves to align helix 3 for mature NTD multimerization.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Expression of the human immunodeﬁciency virus type 1 (HIV-1)
gag gene is sufﬁcient to generate immature viral particles that are
released from infected cells (Wills and Craven, 1991; Spearman et al.,
1994; Reicin et al., 1996; Hermida-Matsumoto and Resh, 1999; Freed,
1998; Mervis et al., 1988; Wang et al., 1998; Ono et al., 2000; Huseby
et al., 2005). Immature particles contain a lipid bilayer envelope
surrounding a shell formed primarily by precursor Gag (PrGag)
proteins (Fuller et al., 1997; Wilk et al., 2001; Wright et al., 2007;
Briggs et al., 2009). Shortly after budding, the viruses undergo a
maturation step, in which the HIV-1 protease (PR) cleaves PrGag into
its mature Gag protein components: matrix (MA), capsid (CA), spacer
peptide 1 (SP1), nucleocapsid (NC), spacer peptide 2 (SP2), and p6
(Wills and Craven, 1991; Mervis et al., 1988; Freed, 1998). Electron
microscopy (EM) studies of mature virus particles have demonstrated
that maturation results in the formation of electron dense conical or
cylindrical cores that are composed of about 1000–1500 capsid
proteins surrounding a ribonucleoprotein complex derived from viral
RNAs and tRNA primers, and enzymatic functions (Wills and Craven,
1991; Freed, 1998; Li et al., 2000; Benjamin et al., 2005; Briggs et al.,
2003, 2006, 2009; Zhao et al., 2013).
HIV-1 CA is a 24 KDa protein that possesses two independently
folded domains connected by a ﬂexible linker. The N-terminal
domain (NTD) is important for formation of CA hexamers and
pentamers, while the C-terminal domain (CTD) contributes to
hexamer formation and also fosters the interconnection of hex-
amers, in part via a CTD dimer interface (Gamble et al., 1996, 1997;
Gitti et al., 1996; Momany et al., 1996; Berthet-Colominas et al.,
1999; Worthylake et al., 1999; Ganser-Pornillos et al., 2007;
Pornillos et al., 2009, 2010, 2011; see Fig. 1). The CA NTD is
composed of seven alpha helices (Fig. 1A), and includes a cyclo-
philin (CypA) binding loop between helices 4 and 5, and an
N-terminal ß-hairpin loop composed of the ﬁrst thirteen residues
of the mature CA protein. The interface formed by NTD helices 1–3
makes NTD–NTD contacts that have proven to be essential for
mature core assembly (von Schwedler et al., 1998; Lanman et al.,
2002; Ganser-Pornillos et al., 2007; Abdurahman et al., 2007;
Pornillos et al., 2009, 2010, 2011; López et al., 2011). These helices
form an 18-helix bundle in which residues near the N-terminal
end of helix 1 are located towards hexamer centers, and have been
shown to be essential for the hexamer formation (Fig. 1B; Ganser-
Pornillos et al., 2004, 2007; Pornillos et al., 2009, 2010, 2011; Zhao
et al., 2013). The CA CTD is smaller than the NTD, and is composed
of a short 310 helix followed by an extended strand and four
α helices (Momany et al., 1996; Gamble et al., 1997, Berthet-
Colominas et al., 1999; Worthylake et al., 1999; Alcaraz et al.,
2007; Wong et al., 2008; Pornillos et al., 2009; Byeon et al., 2009).
The CTD comprises the dimerization interface, which relies on
amino acid residues W184 and M185 (Gamble et al., 1997, Alcaraz
et al., 2008; Byeon et al., 2009; Yu et al., 2009). Interestingly,
Bharat et al. (Bharat et al., 2012) recently reported that signiﬁcant
rotations and translations of the two CA domains occur during the
maturation process of the Mason–Pﬁzer monkey retrovirus.
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One critical event that occurs during HIV-1 maturation is the
proteolytic processing of the N-terminus of the CA protein, which
results in the refolding of the ﬁrst 13 CA residues from an
extended conformation into a β-hairpin loop. Biochemical and
mutational studies have shown that this β-hairpin loop is stabi-
lized by a salt bridge formed between a proline located at position
1 and an aspartic acid at position 51, on the NTD helix 3 (Gamble
et al., 1996; Gitti et al., 1996, Gross et al., 1998; von Schwedler
et al., 1998; Tang et al., 2002; Abdurahman et al., 2007; Monroe
et al., 2010; Wong et al., 2012). Interestingly, the crystal structure
of CA proteins shows no evidence of CA intersubunit interactions
involving the hairpin loop (Pornillos et al., 2009). However, several
laboratories including ours have shown that mutations, deletions
and/or extensions that affect the β-hairpin loop formation are
detrimental for in vitro CA assembly reactions and also for
maturation and infectivity (Gross et al., 1998; von Schwedler
et al., 1998; Abdurahman et al., 2007; Cortines et al., 2011; López
et al., 2011). Therefore, it has been postulated that the presence of
the β-hairpin loop correlates with mature core assembly although
the molecular basis for this requirement remains unclear (Gross
et al., 1998; von Schwedler et al., 1998; Cortines et al., 2011; López
et al., 2011). One possibility proposed for the Equine Infectious
Anemia Virus (EIAV) CA protein is that refolding of the β-hairpin
loop extends helix 1 to enhance the oligomerization of the CA
NTD, but other models for the role of the β-hairpin exist (Chen
et al., 2013).
We recently showed that mutation of I15 near the end of NTD
helix 1 yielded CA variants with defects in in vitro assembly reactions
(López et al., 2011). The location of this residue within CA hexamers
(Fig. 1) implied that it may play a role during maturation by
positioning β-hairpin loops with respect to helices 1 and 3, and an
I15 variant was shown to dominantly interfere with the assembly of
WT CA proteins (López et al., 2011). In our current study, we have
found that an I15A CA mutant assembled replication defective virions.
We also discovered two independent sets of compensatory mutations
that reversed replication defects. One set contained a reversion
of position 15 (alanine to valine; I15V) and a second-site mutation
at residue 16 on helix 1 (serine to asparagine; S16N). The other set of
compensatory mutations showed two second-site changes, one on
the β-hairpin loop (histidine 12 to tyrosine; H12Y), and one on helix 4
(methionine 68 to isoleucine; M68I). More detailed analysis showed
that the H12Y mutation was sufﬁcient to compensate for the defects
of the I15 mutation. Our data indicate that CA NTD β-hairpin residues
serve to ﬁne tune the alignment of helices 1–3 in 18 helix bundles for
the generation of infectious HIV-1 cores.
Results
Analysis of HIV-1 capsid I15 variants
In a recent study (López et al., 2011), we examined the effects of
CA NTD helix 1 mutations on the in vitro assembly of HIV-1 CA
proteins. In particular, we found that mutations at NTD isoleucine
15 (I15) near the N-terminal end of helix 1 (Fig. 1) skewed the
assembly pathway such that spheres and short tubes were
assembled rather than the typical long tubes assembled by wild
type (WT) proteins (Campbell and Vogt, 1995; Gross et al., 1998;
Li et al., 2000; Barklis et al., 2009; López et al., 2011). Moreover,
I15 mutant proteins also had the capacity to dominantly interfere
with the assembly of WT proteins (López et al., 2011). These
observations suggested that I15 side chain interactions are essential
to proper core assembly, and to further analyze the structure and
function of the helix 1 N-terminus, I15 mutants were evaluated in
cell culture.
To analyze the effects of I15 mutations on virus infectivity, HEK
293T cells were transfected with WT and mutant HIV-1 strain NL4-3
constructs, and CA protein-normalized amounts of virus produced
were used to infect MT4 T cells. Virus spread was then monitored by
measuring CA levels via anti-CA immunoblotting from samples of
cells that were passaged at 3–4 d intervals. As shown in Fig. 2A, WT
HIV-1 rapidly infected MT4 T cells with virus levels peaking at 2–4 d
post-infection, prior to cell death. In contrast, the CA I15A mutant
virus levels did not peak until 21–31 d post-infection (Fig. 2A), while
an I15D variant (López et al., 2011) was never detected after serial
passages in MT4 T cells at any virus:cell input ratio (data not shown).
Fig. 1. HIV-1 CA structures. (A) Shown is a ribbon structure (pdb 3H4E) of the HIV-1 CA NTD with the β-hairpin, helices 1–7, and residue I15 indicated. (B) The HIV-1 capsid
hexamer structure is shown as viewed down the sixfold axis from the outside of the mature HIV-1 core. In the model, which derives from pdb 3H4E, the mutated I15 residue
of helix 1 is shown in black and the N-terminal β-hairpin loop is not shown.
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In the case of the I15A mutant, the delayed kinetics of virus
replication observed in Fig. 2A could have been due either to a
stochastic lag in I15A replication or to the generation of revertant
viruses. To distinguish between these alternatives, virus super-
natants of the I15A variant from days 21–24 post-infection were
recovered and used to re-infect new MT4 T cells. Signiﬁcantly,
virus obtained from the late time points of the initial I15A
infections replicated with much faster kinetics than the original
I15A virus stock, suggestive of a reversion and/or compensatory
mutations. These putative revertants were characterized as
described below.
Characterization of compensatory mutations
To examine the capacity of the I15A viruses to evolve compen-
satory mutations, we characterized I15A-derived viruses from two
independent cultures that replicated with faster kinetics than the
parental I15A stock. To do so, proviral DNAs from MT4 T cells
infected with the rapidly spreading I15A variants were PCR-
ampliﬁed, and CA sequences were analyzed. Our analysis indicated
the presence of two different revertants. In the ﬁrst one (I15V/
S16N), the alanine codon at position 15 had mutated to a valine
codon, and the neighboring codon (serine 16) had mutated to an
asparagine codon. In the second revertant (H12Y/I15A/M68I), the
I15A mutation was conserved, but this revertant possessed two
other mutations: one was a H12Y mutation in the β-hairpin loop,
and the second was a M68I mutation in NTD helix 4. To verify that
the capsid mutations that were sequenced actually compensated
for the I15 variations, the I15V/S16N and H12Y/I15A/M68I muta-
tions were cloned into otherwise WT clones of the NL4-3 parental
HIV-1 strain, and tested for their replication efﬁciencies. As shown
in Fig. 2B, the molecularly cloned I15V/S16N variant replicated
with the same kinetics as the WT NL4-3 strain, and the H12Y/I15A/
M68I variant was only slightly delayed. In contrast, the control
I15A virus again showed a replication defect, with virus spread not
occurring until 21–31 d post-infection.
The above results demonstrate that the I15V/S16N HIV-1
variant is capable of efﬁcient replication in MT4 T cells, and imply
that either H12Y, M68I or both mutations compensate for the
original I15A defect. To test the individual contributions of the
selected mutants, molecular clones of H12Y/I15A and I15A/M68A
were constructed and tested in a new experiment. Consistent with
the aforementioned results, the H12Y/I15A/M68I virus replicated
with WT kinetics, and the I15A virus replication was delayed
(Fig. 2C). Signiﬁcantly, the I15A/M68I variant replicated with
somewhat delayed kinetics, with a peak at 9–16 d post-infection,
whereas the H12Y/I15A variant replicated similarly to WT HIV-1
(Fig. 2C), suggesting that the H12Y β-hairpin loop mutation was
predominantly responsible for compensation for the original I15A
mutant. These data could be interpreted to indicate that H12Y and
to a certain extent M68I speciﬁcally correct the I15A defect, or that
the H12Y and M68I viruses are just globally better replicating
viruses in MT4 cells. To distinguish between these alternatives,
replication proﬁles of H12Y and M68I single mutation viruses were
compared with the WT strain. Fig. 2D demonstrates that replica-
tion of the M68I variant was comparable to WT, while H12Y virus
replication was slightly delayed. These results support the notion
that H12Y, and to a lesser extent M68I, speciﬁcally compensate for
the I15A defect.
Single step infection assays
As a complementary analysis of the effects of I15 variants,
single round replication assays were performed. To do so, HIV-1
Fig. 2. Infectivity of HIV-1 CA variants. Viral stocks of WT and CA variant viruses on a NL4-3 HIV-1 strain background were generated by transfection of proviral constructs
into HEK 293T cells. At 3 d post transfection, virus-containing media supernatants were collected, ﬁltered through 0.45 μm ﬁlters and normalized with respect to CA levels.
MT4 T cells were infected in parallel with normalized stocks of the WT and variant viruses and passaged at 3- to 4-day intervals. Virus spread was monitored by measuring
PrGag and CA levels in aliquots of infected cells by immunoblotting using a primary anti-CA antibody. Replication of the WT and variant viruses is plotted as relative CA levels
in infected cells versus number of days post-infection. In all panels mock infections are indicated with white squares and WT infections are depicted with black squares. In
panels A–C, I15A is depicted with white circles. Other infections are as follows: panel B: black triangles, I15V/S16N; black circles H12Y/I15A/M68I. Panel C: black circles,
H12Y/I15A/M68I; black diamonds, H12Y/I15A; black triangles, I15A/M68I. Panel D: white triangles, M68I; white diamonds, H12Y.
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envelope-deleted HIV-Luc luciferase reporter constructs were
cotransfected into human embryonic kidney (HEK) 293T cells with
a VSV envelope glycoprotein expression construct to generate
pseudotyped viruses (Scholz et al., 2005, 2008; Noviello et al.,
2011) that were used to infect HeLa cell-derived CD4þHiJ cells
(Kabat et al., 1994). Not surprisingly, WT HIV-1 viruses were more
than ﬁfty times as infectious as their I15A counterparts (Fig. 3). In
general, results with the other capsid variant mimicked MT4
infection results (Fig. 2). Notably, the I15V/S16N, H12Y/I15A/M68I
and H12Y/I15A variants showed single round infectivity levels of
50–70% WT levels, while the I15A/M68I variant was only slightly
more infectious than the I15A parent. These results support the
observations with replication competent NL4-3 viruses (Fig. 2),
and demonstrate that the I15A defect is not speciﬁc to T cells,
and can not be salvaged by the alternative entry route of VSV
G-pseudotyped virus (Brun et al., 2008).
Analysis of virus particle and release
To measure potential effects of the CA mutations on the release of
virus-like particles (VLP), 293T cells were transfected with each CA
variant construct (WT, I15A, I15V/S16N, H12Y/I15A/M68I, I15A/H12Y,
I15A/M68I, H12Y and M68I) in the context of the replication defective
HIV-Luc background. At 72 h post-transfection, virus and cells sam-
ples were collected and processed. Levels of virus release were
monitored by immunoblotting of SDS-PAGE-fractionated VLP and cell
samples using an anti-CA antibody. As shown for cellular samples
(Fig. 4A–K), we observed some minor variations in WT PrGag, p41
and CA protein levels, depending on the transfection date. (Compare
lanes A, D, I.) Nevertheless, none of the CA variants showed major
differences in either cellular Gag expression or processing levels
(Fig. 4A–K). Similarly, we noted no consistent reductions in VLP
release or VLP Gag processing when VLP samples (Fig. 4, L–V) were
surveyed. However, it is worth mentioning that I15A VLP samples
often showed a species slightly smaller than the size of WT CA (see
especially Fig. 4, lane M), which may represent a CA degradation
product (Scholz et al., 2005), potentially indicative of a virus core
defect as described below.
Effects of I15 CA mutations on virus core morphologies
and in vitro assembly
As shown above, I15A HIV-1 viruses were defective for infec-
tion in both NL4-3 and HIV-Luc backgrounds, while the H12Y
mutation compensated for this defect (Figs. 2 and 3). Moreover,
I15A VLP capsid protein bands showed evidence of abnormalities
on SDS-PAGE gels (Fig. 4), suggestive of a possible virus core
defect. To extend these observations, we examined the core
structures of WT, I15A and H12Y/I15A viruses for possible abnorm-
alities. To do so, VLP from cells transfected with HIV-Luc variants
were isolated and subjected to EM analysis as we have described
previously (Scholz et al., 2005, 2008; Noviello et al., 2011). As we
have seen in the past (Scholz et al., 2005, 2008; Noviello et al.,
2011), WT HIV-1 conical cores were observed both associated with
virus particles (Fig. 5, top left), and as free cores (Fig. 5, top right).
From a total of 169 WT VLPs observed, 63.9% exhibited conical or
cylindrical cores, consistent with previous observations. For I15A
VLPs, considerably fewer particles showed conical or cylindrical
cores (46.6% of 161 particles). Frequently, particles with no obvious
cores were observed (Fig. 5, middle left panel), and even when
cores were evident, they often appeared anomalous (middle right
panel). However, when I15A was expressed in the presence of the
compensatory HIV12Y mutation (H12Y/I15A), particle-associated
cores and free cores appeared normal (Fig. 5, bottom panels).
Additionally, a higher percentage of H12Y/I15A virus (61.7% of 167
particles) showed conical or cylindrical cores, suggesting that the
H12Y change in the β-hairpin loop corrected the I15A defect at the
N-terminus of NTD helix 1.
We further examined the role of the H12Y compensatory mutation
by exploiting in vitro assembly assays using puriﬁed CA proteins. For
this approach, WT, I15A and H12Y/I15A CA proteins were expressed in
bacteria, puriﬁed, and employed in in vitro assembly reactions (Barklis
et al., 2009; López et al., 2011). To do so, puriﬁed proteins at 60 mM
were induced to assemble at 4 1C for 48 h and then processed for
visualization by EM. As shown in Fig. 6 (top panel) WT CA proteins
assembled long tubes, which are representative of a mature assembly
phenotype (Gross et al., 1998; Li et al., 2000; Ganser-Pornillos et al.,
2004; Barklis et al., 2009; López et al., 2011). In contrast, I15A CA
proteins (Fig. 6) assembled short tubes and spheres, indicative of a
Fig. 3. Single step infection assays. Luciferase gene-transducing HIV viruses were
produced by cotransfection of HEK 293 T cells with a VSV-G expression plasmid for
the indicated HIV variants. At 3 d post-transfection, virus-containing medium
supernatants were collected, ﬁltered through 0.45 μm ﬁlters, and used to infect
HiJ cells plated the day before in 6-well plates. At the same time HEK 293T cell
samples were collected to normalize for transfected cell HIV-Luc expression levels.
At 3 d post-infection, the HiJ cells were collected and processed for luciferase
assays. The results are depicted as luciferase activity signals in infected cells divided
by transfected cell signals and normalized to values obtained with the WT HIV-Luc
virus. The results are the values obtained using duplicates of two independent viral
stocks for the revertants and four viral stocks for the WT and I15A mutant. Standard
deviations are as shown.
Fig. 4. Analysis of virus particle and release. HEK 293 T cells were transfected with
the indicated HIV-Luc constructs. At 72 h post transfection, virus samples were
collected and concentrated through 20% sucrose cushions at 197,000g. Gag proteins
from collected cells (top panel lanes A–K) and virus (bottom panel lanes L–V) were
detected after SDS-PAGE by immunoblotting using a primary anti-CA antibody.
Full-length PrGag, p41 and CA bands are indicated.
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mature core assembly defect. However, the double H12Y/I15A mutant
yielded tube numbers and morphologies similar to WT, demonstrat-
ing that H12Y counteracts the I15A defect. To quantify in vitro
assembly results, tube lengths and areas covered by tubes were
determined and normalized toWT tube values (Fig. 6, bottom panels).
As illustrated, the I15A CA mutant gave lower numbers of CA tubes
than WT or H12Y/I15A, as measured by tube coverage. Additionally,
the average tube length for the few I15A tubes obtained was 50%
shorter relative to the signiﬁcantly higher numbers of WT and H12Y/
I15A tubes. Thus, in vitro assembly results (Fig. 6) correlate with our
virus core morphology analysis (Fig. 5), and support a model in which
the H12Y mutation rescues the I15A replication defect by restoring
normal virus core morphology. Details of the H12–I15 interaction are
discussed below.
Discussion
Structural analysis has indicated that the ﬁrst three helices of
the HIV-1 CA NTD coordinate CA hexamer and pentamer forma-
tion in mature virus cores (Ganser-Pornillos et al., 2004, 2007;
Pornillos et al., 2009, 2010, 2011). Interestingly, evidence based on
the Mason–Pﬁzer monkey virus (MPMV) suggests that helices 1–3
do not serve such a role in immature virus particle lattices (Bharat
et al., 2012). This is consistent with the fact that virus maturation
is accompanied by the formation of the NTD β-hairpin loop and
the establishment of a salt bridge between CA proline 1 (P1)
and aspartate 51 (D51) in helix 3. In EIAV, the formation of the
β-hairpin loop serves to extend NTD helix 1 several residues in
the N-terminal direction (Chen et al., 2013), potentially stabilizing
mature capsid hexamers, but the precise structural contributions
of retroviral β-hairpin and nearby residues with regard to viral
morphogenesis are still unclear.
HIV-1 CA NTD residue I15 occupies a position near the N-
terminus of helix 1, and adjacent to the P1-D51 salt bridge.
Previously, we had shown that puriﬁed I15D and I15A proteins
assembled immature-like spheres and small tubes rather than
mature form long tubes in in vitro assembly reactions (López et al.,
2011). Here, we have demonstrated that while I15 mutant Gag
proteins are capable of assembling and releasing virus particles
from cells (Fig. 4), the virions are replication defective and their
mature cores are aberrant (Figs. 2,3,5). Selection for revertants
of the I15A mutation yielded I15V/S16N and H12Y/I15A/M68I
variants (Fig. 2). The selection of the I15V/S16N variant was
not unexpected, since a variety of hydrophobic amino acids at
CA residue 15 have been found in HIV-1 strains (Table 1). The
H12Y/I15A/M68I variant was more interesting because it indicated
that H12Y and/or M68I compensated for the I15A defect. Perhaps
not surprisingly, separation of the two secondary mutations
showed that M68I, located away from helix 1 (Fig. 7A), yielded
only a small compensatory effect (Figs. 2 and 3), whereas H12Y
was predominantly responsible for rescue of infectivity and virus
core structure (Figs. 2, 3, 5 and 6).
How does the H12Y mutation in the β-hairpin loop rescue the
I15A mutant? Examination of the I15 side group (Fig. 7B), suggests
that it is positioned to make important intramolecular contacts
rather than critical intermolecular CA–CA contacts. Speciﬁcally, it
is positioned to help align the N-terminal portion of NTD helix 1,
potentially through interactions with T19 and L20, and to align
helix 3 through interactions with T54. Of these two roles, the H12Y
change appears more likely to affect the helix 3 alignment. In
particular, a tyrosine at CA residue 12 is capable of hydrogen
bonding to helix 3 residue Q50 (Fig. 7C), next to the P1–D51 salt
bridge. We thus envision that while P1–D51 and I15–T54 interac-
tions ordinarily help align the CA helix 3 N-terminus in mature
virions, the I15–T54 interaction is replaced by the H12Y-Q50
hydrogen bonding in the H12Y/I15A double mutant. One conse-
quence of having neither of these interactions is that a fraction of
the CA I15A proteins in virions appears to be clipped (Fig. 4, Lane
M), potentially near the β-hairpin-helix 1 juncture. In contrast, the
consequences of having both I15 and H12Y do not prohibit HIV-1
replication, but may impart a very slight replication disadvantage
(Figs. 2 and 3). This may be related to the fact that of the 2% of
HIV-1 strains that carry H12Y (Table 1), all also have either a
leucine or valine rather than an isoleucine at residue 15.
In terms of how alterations of the NTD helix 3 alignment might
perturb HIV-1 morphogenesis, the percentage of conical, albeit
anomalous cores formed with the I15A mutant suggest that
I15A does not trap CA in an immature conformation. Instead, we
speculate that the small variance in the I15A alignment of helices
1 and 3 yields CA proteins that either increase the frequency of
pentamers versus hexamers (Ganser-Pornillos et al., 2004, 2007;
Pornillos et al., 2009, 2010, 2011), or increase the probability that
growth of mature core lattices will be terminated prematurely
(Barklis et al., 2009; López et al., 2011). Either way the sensitivity
of this region of CA to mutation suggests that the cavity occupied
by I15 would be a worthwhile target for antivirals.
Fig. 5. Effects of I15 CA mutations on virus core morphologies. WT, I15A and I15A/
H12Y HIV-Luc viruses from transfected HEK 293 T cells were concentrated through
20% sucrose cushions at 197,000g, resuspended in cold PBS and subjected to a
second round of ultracentrifugation at 149,000g, adhered to carbon-coated EM
grids, stained, and visualized by EM. Representative viral particles or isolated cores
for WT, I15A and I15A/H12Y are depicted. The size bar for all the panels is provided
at the bottom right. Percentages of viruses with conical or cylindrical cores based
on at least 150 virus counted were as follows: WT, 63.9%; I15A, 46.6%; H12Y/
I15A, 61.7%.
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Materials and methods
Recombinant DNA constructs
The Vesicular Stomatitis virus (VSV) glycoprotein (G) expression
construct, pVSV-G, used for envelope pseudotyping was described
previously (Scholz et al., 2005, Noviello et al., 2011) and was a
generous gift from Randy Taplitz. The parental HIV-Luc construct
(pNL-LucE-Rþ; Connor et al., 1995) was kindly provided by Nathaniel
Landau. The parental HIV-1 NL4-3 molecular clone was obtained from
the NIH AIDS reagent program. The parental construct used for HIV-1
CA expression in bacteria is pWISP-WTCAH6 (Barklis et al., 2009)
which expresses C-terminally histidine-tagged (his-tagged) CA pro-
teins. It derives from pWISP-98-85 (Li et al., 2000; Ganser-Pornillos
et al., 2004), which was kindly provided by Wes Sundquist.
The I15A point mutation was created by polymerase chain
reaction (PCR) approaches as described previously (López et al.,
2011) and was veriﬁed by sequencing. Its sequence is given below,
where bold nucleotides correspond to the mutated residues, and
underlined nucleotides represent silent mutations that create or
destroy restriction enzyme cleavage sites: CAT CAG GCC GCT AGC
CCT. The mutation was subcloned into pNL4-3 and HIV-Luc
constructs using BssHII–ApaI (HIV-1 viral nt 711–2006) fragments,
and mutations were conﬁrmed by sequence analysis.
Compensatory mutations were cloned from longitudinal
passages of MT4 T cells infected with the NL4-3 I15A virus. To do
so, total DNA samples were isolated from infected MT4-T cells. For
this, cells were lysed in 250 ml cold IPB buffer (20 mM Tris, pH 7.5,
150 mM NaCl, 1 mM ethylenediaminetetraacetic acid [EDTA],
0.02% sodium azide, 1% Triton X-100, 0.5% sodium deoxycholate,
0.1% sodium dodecyl sulfate [SDS]) for 5 min on ice after which
250 ml of water was added. Cellular extracts were then treated
with 2.5 ml of proteinase K (20 mg/ml) for 2 h at 501C. DNA was
isolated by two 500 ml phenol–chloroform extractions followed
by a 500 ml chloroform extraction. The aqueous phase was then
Fig. 6. In vitro assembly of puriﬁed HIV capsid proteins. WT, I15A and H12Y/I15A CA proteins were expressed in bacteria, puriﬁed, and employed in in vitro assembly
reactions. Puriﬁed proteins at 60 μM were induced to assemble at 4 1C for 48 h and then processed for visualization by EM, as shown in the top panels, where fewer capsid
tube assembly products were observed for I15A than the WT or H12Y/I15A proteins. To quantify assembly efﬁciencies, tube coverage values were calculated from ten
14,37014,370 μm2 ﬁelds of view as described in the Materials and methods. Results in the bottom left panel are given as areas covered by tubes after normalization of
results obtained with WT CA. A T test analysis showed the tube coverage difference between I15A and the other two samples to be signiﬁcant to a probability of Po0.008.
In the bottom right panel, tube lengths in microns were quantitated using low magniﬁcation images and results are depicted as mean tube lengths plus standard deviations.
A T test analysis showed the length difference between I15A and the two other samples to be signiﬁcant to a probability of Po0.006.
Table 1
Amino acid frequency at CA positions 12 and 15. HIV-1 genome sequences obtained
from the HIV sequence compendium HIV-1/SIVcpz (http://www.hiv.lanl.gov/con
tent/index) were analyzed for frequency of amino acids in capsid postions 12
and 15.
Amino acid frequency (%)
Position Val Met Ile Leu Tyr His Other
12 0 0 0 0 2.0 97.0 1.0
15 4.5 5.9 45.3 44.3 0 0 0
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treated with 1/10 volume (40 ml) of plasmid-free 3 M sodium
acetate pH 7.6 and 2.5 vol (1 ml) of cold plasmid-free 100%
ethanol. The DNA was precipitated for 1 h at 801C, pelleted by
centrifugation for 5 min at 16000g, and the ethanol excess was
dried using a speed-vac. The DNA samples were resuspended in
150 ml of plasmid-free 10 mM Tris pH7.4, 0.1 mM EDTA, aliquoted
and stored at 20 1C. Puriﬁed DNAs (1–5 ml) then were used as
templates for PCR ampliﬁcation reactions. The sequences between
nt 671 and 2121 (pNL4-3 nt sequence) were ampliﬁed using
ThermoPol Polymerase (New England Biolabs) using standard
PCR protocols and subcloned into pGEMTeasy vector (Promega)
for sequence analysis. The obtained capsid revertants were then
subcloned back into both HIV-Luc and pNL4-3 constructs using
BssHII–ApaI sites (nt 711 to 2006), and sequenced again. The
sequences obtained for the compensatory mutants are as follows:
I15V/S16N: CAT CAG GCC GTT AAC CCT; H12Y/I15A/M68I: TAT CAG
GCC GCT AGC and CAA ATA TTA AAA for M68I where bold
nucleotides correspond to the mutated residue and underlined
nucleotides represent silent mutations that create or destroy
restriction enzyme cleavage sites.
To create the double H12Y/I15A and I15A/M68I HIV-Luc and
pNL4-3 constructs BssHII–NsiI (nt 711–1248) and NsiI–ApaI (nt
1248–2006) sites were used respectively. For the latter construct
HIV-Luc and pNL4-3 I15A variants were used as parentals. The
single M68I variant HIV-Luc and pNL4-3 constructs were created
by using NsiI–ApaI (nt 1248–2006) sites into WT parental con-
structs. For the single H12Y construct, the sequences between nt
671 and 1248 (pNL4-3 nt sequence) were ampliﬁed using Thermo-
Pol Polymerase using standard PCR protocols and subcloned
into pGEMTeasy vector for sequence analysis. To create the H12Y
HIV-Luc and pNL4-3 constructs, BssHII–NsiI (nt 711–1248) sites
were used. For bacterial CA protein expression, the compensatory
mutations were ampliﬁed from their respective HIV-Luc con-
structs by PCR to create NdeI sites at the 5′ ends of the capsid
genes, subcloned into pGEMTeasy, sequenced, and then subcloned
into pWISP-6H using NdeI–SpeI (nt 1187–1511) sites.
Cell culture, transfections and infections
HEK 293T (DuBridge et al., 1987) and HiJ (Kabat et al., 1994)
cells were maintained in Dulbecco's modiﬁed Eagle's medium
(DMEM) supplemented with 10% fetal bovine serum (FBS), 10 mM
HEPES (pH 7.4), penicillin, and streptomycin at 37 1C and 5% CO2.
The MT4 T cell line used for longitudinal passages was maintained
in Roswell Park Memorial Institute medium (RPMI) supplemented
with 10% FBS, 10 mM HEPES (pH 7.4), penicillin, and streptomycin
at 37 1C and 5% CO2.
For analysis of virus from cells, HEK 293T cells were transfected
with 24 mg HIV-Luc plasmids using calcium phosphate as
described previously (Scholz, et al., 2005, 2008; Noviello et al.,
2011). At 72 h post-transfection, virus samples were collected by
ﬁltering supernatants through 0.45 μm ﬁlters, pelleted at 100,000g
through 20% sucrose cushions at 4 1C and then resuspended in
100 ml of cold phosphate-buffered saline (PBS: 137 mM NaCl,
2.7 mM KCl, 10 mM NaH2PO4, 2 mM KH2PO4, pH 7.4), stored at
80 1C and mixed 1:1 with loading buffer (40 mM DTT, 0.25%
bromophenol blue, 4% SDS, 20% glycerol, 125 mM Tris pH 6.8, 10%
β-mercaptoethanol) prior to electrophoresis.
Cell samples from 10 cm plates were washed in 2 ml of cold
PBS, collected in 1 ml of cold PBS, and 200 ml aliquots of the
suspended cells were centrifuged and lysed by suspension for
5 min in 50 μl of cold IPB buffer on ice. Insoluble cellular debris
was removed via centrifugation for 15 min at 16,000g at room
temperature. Cell lysates were mixed with equal amounts of
loading buffer and then stored at 80 1C. Both virus and cell
samples were fractionated by 10% SDS-polyacrylamide gel electro-
phoresis (SDS-PAGE) and subsequently immunoblotted as
described previously (Scholz et al., 2005, 2008; Noviello et al.,
2011). For immunoblotting, the monoclonal mouse anti-CA anti-
body Hy183 (kindly provided by Bruce Chesebro) was used at a
1/10 dilution (from hybridoma supernatants) as the primary anti-
body. Secondary antibodies were alkaline phosphatase-conjugated
anti-mouse antibodies (Promega) used at a 1/10,000 dilution. BCIP
(5-bromo-4-chloro-3-indolyl-phosphate) was used in conjunction
with NBT (nitro blue tetrazolium) for the colorimetric detection of
alkaline phosphatase activity. Cell and virus Gag levels were
quantiﬁed densitometrically using NIH ImageJ. Mean gray values
for each CA band were measured for the same-sized areas on blots.
To perform the luciferase-based infectivity assays, HEK 293T cells
were transfected as described above using 18 mg of HIVLuc and 6 mg of
pVSV-G plasmids. At 72 h post-transfection, supernatants containing
viral particles were ﬁltered through 0.45 μm syringe ﬁlter, aliquoted
and stored at80 1C. Aliquots of the transfected cells were collected in
cold luciferase assay buffer (LAB) (100 mM sodium phosphate [pH
8.0], 4 mM adenosine triphosphate, 1 mM sodium pyrophosphate,
6 mM magnesium chloride, 0.2% Triton X-100) and frozen at 80 1C
to be used as transfection controls. For the infections, conﬂuent HiJ
cells were transferred from a 10 cm dish to a 6 well plate at a 1:4
dilution the day before the infections. One day later, HiJ cells were
incubated with 1 ml of virus, 1 ml of culture media, and 10 μl of
1.6 mg/ml polybrene in duplicate and then incubated at 37 1C, 5% CO2
Fig. 7. Locations of mutant CA residues. Panel A shows the locations of CA residues H12 (red), I15 (black) and M68 (purple) on the HIV-1 CA hexamer structure (pdb 3GV2).
Panels B and C each show CA NTD monomer structures (from pdb 3GV2), with helix 1 in red, helix 2 in green, and helix 3 in pink. In both B and C, residues 12 and 15 are
colored light blue and marked; and residues T19 and L20 (red); Q50, D51, and T54 (pink); and P1 (blue) are as indicated. Panel B shows the WT protein, whereas panel C
shows a model of the H12Y/I15A protein. The predicted hydrogen bond between H12Y and Q50 is depicted by the brown bar.
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for 72 h. Three days post-infection cells were washed with cold PBS,
lysed in 250 μl LAB buffer and frozen at 80 1C before assays. In all
cases samples from transfected and infected cells were diluted at 1:10
or 1:20 in LAB buffer lacking Triton X-100 and run on a Centro XS3 LB
960 Microplate Luminometer (Berthold Technologies). The 96-well
plates used were Microﬂuor 1 white (Nunc # 7705). The luciferin
volume injected was set for 100 ml per well of a freshly prepared
1 mM luciferin solution (BD Monolight) with counting times of 15 s
per well. The obtained relative light units were calculated as (average
of infection duplicate counts)/(average of transfection counts) and
subsequently normalized to WT samples.
For the longitudinal infections of virus in MT4 T cells, 24 mg of
pNL4-3 wild type DNA or I15 variants were transfected via calcium
phosphate into HEK 293T cells. At 3 d post-transfection, viral
supernatants were ﬁltered through 0.45 μm ﬁlters and aliquots
of each stock were subjected to SDS-PAGE and immunoblotting for
virus quantitation. For viral inoculum normalization, CA bands
were quantiﬁed from immunoblots using NIH ImageJ software
package and used as starting inocula for infections of 5 ml MT4
cells. After infections, aliquots of cells (20% of the cultures) were
collected every 2–4 d, centrifuged for 3 min at 16,000g, lysed in
cold IPB buffer and stored at 80 1C prior to analysis. Infections
were tracked by immunoblot detection of infected cell CA levels
using the mouse anti-CA monoclonal antibody Hy183 described
above. Potential compensatory mutant viruses from late-stage
collections were used to re-infect fresh stocks of MT4 cells after
normalization against the WT virus. These secondary passages also
were monitored by CA immunobloting, and the compensatory
mutations were cloned as described above.
Virus particle analysis
HIV-Luc wild type (WT) and I15 variant virus-like particles were
produced by calcium phosphate transfection of 24 mg of plasmid DNA
of HEK 293T cells. Supernatants were ﬁltered through 0.45 μm ﬁlters,
and subjected to ultracentrifugation through 20% sucrose cushions as
describe above. Pelleted virus samples were gently resuspended in
100 μl cold PBS and subjected to a second round of centrifugation
using a Beckman airfuge ultracentrifuge for 15 min at 149,000g in a
A100/18 ﬁxed angle rotor. These virus pellets were gently suspended
in 15 μl of cold PBS and processed for EM. Brieﬂy, 8 μl drops were
deposited onto UV irradiated EM grids (Ted Pella 01824) for 3 min,
rinsed 15 s in water, wicked, stained 1min in ﬁltered 1.3% uranyl
acetate, wicked, and air dried. EM images were collected at 100 kV on
a Philips CM120/Biotwin transmission electron microscope (TEM).
Images were collected as 1024- by 1024-pixel, 14-bit grayscale Gatan
digital micrograph 3 (DM3) ﬁles on a Gatan 794 multiscan CCD
camera and converted into 8-bit grayscale TIFF images using the
program Digital Micrograph 3.4.0. Raw images were acquired at
8400 and 27,500 . Virus particles from at least 100 images
per sample were examined for the presence of conical or cylindrical
cores to determine the percentage of particles with normal core
morphologies.
Puriﬁcation of bacterially expressed CA proteins
pWISP-6H plasmids containing WT or mutant CA seqeunces were
transformed into the E. coli strain BL21(DE3)/pLysS (Novagen) for
protein expression and puriﬁcation, which followed previous proce-
dures (Barklis et al., 2009; Noviello et al., 2011; López et al., 2011).
Brieﬂy, bacteria were grown in Luria-Bertani (LB) broth supplemented
with 0.02% maltose and 10mM MgSO4 to a 600 nm optical density
(OD) of about 0.4, and then induced at 25 1C for 3 h via the addition of
0.5 mM isopropyl-β-D-thiogalactopyranoside (IPTG; Roche #114114
46001). Induced bacteria were collected by centrifugation (Sorvall
GSA 5000 rpm, 3000g, 4 1C) and frozen at 80 1C. Bacterial pellets
were suspended in 10 ml of ice cold 50 mM NaH2PO4 pH 7.8, 300 mM
NaCl containing 0.5 mg of DNaseI (Roche #10104159001) plus pro-
tease inhibitors (15 μg/ml leupeptin, 36 μg/ml egg-white trypsin
inhibitor, 36 μg/ml soybean trypsin inhibitor, 30 μg/ml aprotinin, and
1.5 mM phenylmethylsulfonyl ﬂuoride [PMSF]; Sigma). After a 10 min
incubation on ice, bacterial suspensions were French-pressed twice,
cleared by centrifugation at 23,000g (Sorvall SS34, 14,000 rpm) for
15 min at 4 1C, and puriﬁed by one to two rounds of nickel chelate
chromatography (Qiagen Ni-NTA resin, #30210). Non-speciﬁc protein
contaminants were washed by increasing the imidazole concentration
(10 mM, 25mM and 50mM) in wash buffer (50 mM NaH2PO4 pH 6,
300 mM NaCl, 10% glycerol), and CA proteins subsequently were
eluted in the same buffer containing 250mM imidazole. Puriﬁed
fractions were subjected to three rounds of buffer exchange by dialysis
in 20 mM Tris pH 8.0, 5 mM β-mercaptoethanol for 6 h at 8 1C and
protein aliquots were ﬂash frozen on dry ice and stored at 80 1C.
Protein identities were assessed by immunoblotting, and protein
purities of 490% were veriﬁed by Coomassie blue staining of samples
fractionated in 10% sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE). Protein concentrations were determined via
280 nm absorbance readings assuming a molar extinction coefﬁcient
of 33,580, and by densitometric comparison of stained SDS-PAGE
protein bands versus known standards.
Analysis of in vitro CA assembled products
In vitro assembly capsid incubations were performed as described
previously (Barklis et al., 2009; Noviello et al., 2011; López et al., 2011).
Typically, 10 μl reactions included 1.5 mg/ml protein (ﬁnal concentra-
tion) and 1 assembly buffer (50 mM Tris pH 7.0, 1 M NaCl and
5mM β-Me), and were incubated 48 h at 41 C. After this incubation
step, the samples were lifted 3 min onto UV-irradiated 400-mesh
carbon-formvar grids (Ted Pella 01822-F), washed for 1 min in water,
wicked on ﬁlter paper, stained 45 s in ﬁltered 1.33% uranyl acetate,
wicked, and air dried. Samples were viewed at 100 kV on a Philips
CM120 Biotwin and images were collected as described above.
Tube lengths for each CA variant were manually measured using at
least ten 4800 gray scale TIF images corresponding to areas of
4.1364.136 μm2. Tube area coverage was determined as described
previously López et al., 2011). Brieﬂy, image features were highlighted
using gray scale TIF images and the Feature J/FJ Laplacian command
with a smoothing step of 10, and the zero crossings parameter
unselected. Laplacian images were thresholded to low values of 0.10
and maximum high values. For tube coverage tabulation, the Analyze/
Analyze Particles command was used with the Analyze/Set Measure-
ments area and Feret's diameter options highlighted. The Analyze
Particles command was called with size and circularity arguments,
and results (including particle ID numbers, particle areas, and Feret
diameters) were saved in table format. Tube candidates then were
excluded if they did not meet the criteria of having a Feret's diameter
of at least 50, and a (Feret)2/(area) value of at least 4. After performing
these qualiﬁcation steps, total areas covered by tubes were summed
and divided by total areas to obtain area fractions covered by tubes.
Results are depicted as areas covered by tubes normalized to the
results with wild type incubations.
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